nderstanding Q-detect: Coxiella burnetii exposure and the humoral and cellular immune response

Completed

• Conditions: Coxiella burnetii infection; Q-fever; 10004018

• Registration Number: NL-OMON41033
• Lead Sponsor: Innatoss Laboratories BV

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 125

Inclusion Criteria

Healthy volunteers: random group
Patients: known Q fever infection in past or present

Exclusion Criteria

Healthy volunteers: history of Q-fever
All: presence of active infection, HIV, Hepatitis, blood-borne disease (all based on knowledge of subject)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Percentage Q-detect positive individuals in a low incidence region</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Definition of a cytokine and antibody profile of Q-detect* positive individuals<br /><br>in comparison to known Q fever patients. </p><br>